US · ATEC
Alphatec Holdings, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Carlsbad, CA 92008
- Website
- atecspine.com
Price · as of 2025-12-31
$10.43
Market cap 2.02B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $38.58 | +269.89% |
| Intrinsic Value(DCF) | $35.65 | +241.8% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $24.84 | $385.15 | $22.80 | $0.00 | $0.00 |
| 2012 | $25.32 | $60.85 | $1.62 | $0.00 | $0.00 |
| 2013 | $15.12 | $52.92 | $0.00 | $0.00 | $0.00 |
| 2014 | $17.64 | $624.15 | $0.00 | $0.00 | $0.00 |
| 2015 | $3.48 | $233.04 | $0.00 | $0.00 | $39.14 |
| 2016 | $3.54 | $327.97 | $0.00 | $0.00 | $89.54 |
| 2017 | $3.43 | $41.49 | $0.00 | $0.00 | $1.18 |
| 2018 | $2.49 | $16.29 | $0.00 | $0.00 | $1.02 |
| 2019 | $5.55 | $25.38 | $0.00 | $0.00 | $0.00 |
| 2020 | $16.76 | $30.54 | $0.20 | $0.00 | $0.00 |
| 2021 | $10.61 | $32.11 | $107.79 | $0.00 | $0.00 |
| 2022 | $14.30 | $30.81 | $70.56 | $0.00 | $0.00 |
| 2023 | $12.80 | $29.69 | $546.46 | $0.00 | $0.00 |
| 2024 | $10.46 | $30.36 | $177.05 | $0.00 | $0.00 |
| 2025 | $13.47 | $38.58 | $121.82 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Alphatec Holdings, Inc.'s (ATEC) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $38.58
- Current price
- $10.43
- AI upside
- +269.89%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$35.65
+241.8% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ATEC | Alphatec Holdings, Inc. | $10.43 | 2.02B | +270% | +242% | — | — | -14.10 | 56.10 | 2.65 | -62.48 | — | -15.24 | 69.60% | -10.75% | -18.76% | -630.66% | -16.83% | -18.30% | 17.21 | -3.88 | 2.06 | 1.18 | -11.57 | -1504.00% | 2495.00% | -10201.00% | 0.14% | 0.21 | 0.57% | 0.00% | 0.00% | 0.59% | -30.20 | 893.55 | 3.25 | 0.06 |
| ADPT | Adaptive Biotechnologies … | $16.02 | 2.46B | +132% | +239% | — | — | -41.11 | 11.18 | 8.83 | -83.74 | — | 24.93 | 74.24% | -20.62% | -21.48% | -28.23% | -33.39% | -11.31% | 1.28 | -4.85 | 3.34 | 3.08 | -7.04 | -6389.00% | 5477.00% | -5050.00% | -2.00% | -0.51 | -28.61% | 0.00% | 0.00% | 0.00% | -43.75 | -51.06 | 9.02 | 2.04 |
| CDTX | Cidara Therapeutics, Inc. | $221.38 | 5.61B | -67% | -96% | — | +934% | -0.88 | 0.92 | 117.83 | 0.20 | -0.22 | 0.92 | -6557.49% | -13811.92% | -13319.76% | -218.99% | 567.59% | -120.52% | 0.02 | — | 4.25 | 3.86 | 1.06 | 40952.00% | -9800.00% | 67021.00% | -117.59% | -3.56 | 569.40% | 0.00% | 0.00% | 103.41% | 0.20 | 0.20 | -28.25 | -4.03 |
| HTFL | Heartflow, Inc. Common St… | $23.16 | 1.97B | — | — | — | — | — | — | — | — | — | — | 75.07% | -48.66% | -76.65% | 11.78% | 8.22% | -63.49% | -0.19 | -2.69 | 2.45 | 2.33 | -1.67 | -2320.00% | 4432.00% | -1112.00% | — | -2.05 | 9.85% | — | 0.00% | — | — | — | — | — |
| IDYA | IDEAYA Biosciences, Inc. | $32.20 | 2.83B | +1,323% | +773% | -84% | — | -25.71 | 2.86 | 13.37 | -14.94 | — | 2.86 | 97.90% | -72.84% | -51.99% | -10.92% | -39.17% | -10.18% | 0.03 | — | 11.34 | 10.87 | 0.55 | -6190.00% | 302443.00% | -7078.00% | -2.51% | -1.21 | -18.06% | 0.00% | 0.00% | 0.67% | -14.51 | -31.47 | 10.57 | 19.76 |
| IRON | Disc Medicine, Inc. | $66.62 | 2.51B | — | — | — | — | -11.07 | 3.17 | — | -7.50 | -21.38 | 3.17 | 0.00% | — | — | -35.86% | 717.87% | -32.55% | 0.00 | -65.43 | 21.94 | 21.59 | 0.43 | 5177.00% | — | 9202.00% | -7.72% | -4.92 | 551.51% | 0.00% | 0.00% | 0.00% | -6.61 | -8.60 | — | 20.31 |
| LEGN | Legend Biotech Corporatio… | $19.00 | 1.75B | +139% | +396,718% | -91% | — | -20.39 | 3.10 | 5.14 | -21.66 | — | 3.72 | 62.60% | -48.35% | -28.22% | -13.80% | -112.36% | -8.99% | 0.34 | -14.03 | 4.62 | 4.49 | -0.56 | -6701.00% | 11997.00% | -6199.00% | -4.91% | -0.52 | -58.59% | 0.00% | 0.00% | 0.00% | -8.08 | -15.50 | 3.91 | 2.18 |
| LIVN | LivaNova PLC | $70.60 | 3.86B | +8% | -48% | — | — | -15.79 | 3.19 | 2.76 | -28.32 | — | 21.61 | 67.71% | 14.36% | -17.47% | -19.24% | 15.30% | -9.49% | 0.39 | 4.04 | 1.36 | 1.05 | 1.25 | -48362.00% | 1074.00% | 2742.00% | 4.52% | 0.31 | 13.29% | 0.00% | 0.00% | 10.83% | 18.39 | 21.17 | 2.64 | 2.55 |
| SGRY | Surgery Partners, Inc. | $15.50 | 2B | +214% | -38% | — | — | 242.66 | 1.69 | 0.97 | 12.90 | 18.60 | -0.91 | 23.94% | 11.20% | -5.40% | 0.66% | 2.77% | 0.17% | 2.07 | 1.73 | 1.79 | 1.36 | 6.85 | 130444.00% | 1352.00% | 229.00% | 6.91% | 0.48 | 4.16% | 0.00% | 0.00% | 0.00% | 18.54 | 30.84 | 2.08 | 0.91 |
| SRRK | Scholar Rock Holding Corp… | $44.27 | 4.52B | — | — | — | — | -14.59 | 9.75 | — | -13.57 | -60.50 | 9.81 | 0.00% | — | — | -82.95% | -14081.23% | -62.67% | 0.18 | -36.87 | 9.61 | 9.36 | 0.47 | 2412.00% | — | 3837.00% | -5.59% | -4.28 | -11231.68% | 0.00% | 0.00% | 2.02% | -12.78 | -16.03 | — | 16.84 |
| ZLAB | Zai Lab Limited | $19.22 | 2.13B | +50% | -49% | — | — | -11.49 | 2.82 | 4.38 | -9.81 | — | 3.16 | 58.60% | -49.86% | -38.15% | -22.56% | -97.09% | -14.89% | 0.31 | -44.05 | 2.45 | 1.91 | 2.88 | -3846.00% | 1533.00% | -4251.00% | -7.88% | -0.36 | -68.36% | 0.00% | 0.00% | 7.89% | -6.77 | -9.77 | 3.37 | -0.13 |
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
- CEO
- Patrick S. Miles
- Employees
- 867
- Beta
- 1.01
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($35.65 ÷ $10.43) − 1 = +241.8% (DCF, example).